Elevation of N epsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. - Yagmur,E.; Tacke,F.; Weiss,C.; Lahme,B.; Manns,MP.; Kiefer,P.; Trautwein,C.; Gressner,AM. (Clin Biochem, 2006)